Machine Learning Cancer Biomarker Discovery Pipeline

Deep Learning Feature Extraction from Histopathology Images

This research investigates convolutional neural networks and transformer architectures for automated extraction of morphological and architectural features from whole-slide pathology images. The work advances interpretable biomarker discovery by identifying novel tissue-level patterns predictive of treatment response and patient prognosis.

Multi-Omics Integration via Graph Neural Networks

This study explores graph neural network frameworks that simultaneously integrate genomic, transcriptomic, proteomic, and metabolomic data to model cancer system biology. The research produces unified biomarker signatures that capture inter-omics dependencies and predict therapeutic vulnerability.

Temporal Sequence Modeling of Longitudinal Cancer Evolution

This investigation applies recurrent neural networks and attention mechanisms to track clonal evolution and biomarker dynamics across serial tumor sampling and treatment timepoints. The work generates predictive models of cancer progression trajectories and resistance mechanisms.

Explainable AI for Clinical Biomarker Interpretation and Validation

This research develops SHAP, LIME, and attention-based interpretability methods to deconstruct machine learning predictions into clinically actionable biomarker components. The work bridges computational discovery and clinical translation by validating which learned features correspond to biologically meaningful cancer signatures.

Adversarial Domain Adaptation for Cross-Cancer Biomarker Transfer

This study leverages adversarial neural networks to align biomarker distributions across different cancer types and patient cohorts while minimizing domain-specific batch effects. The research enables discovery of universal cancer hallmark signatures and improves generalization of predictive models.

Single-Cell RNA-Seq Analysis via Clustering and Trajectory Inference

This research applies unsupervised learning, dimensionality reduction, and pseudotime analysis to dissect tumor microenvironment heterogeneity and identify rare cell populations with prognostic significance. The work discovers developmental trajectories of cancer cells and immune infiltrates linked to immunotherapy response.

Transfer Learning from Natural Images to Cancer Image Classification

This investigation examines how pre-trained deep learning models on ImageNet and medical imaging datasets can be fine-tuned for cancer histology and radiology biomarker detection. The research demonstrates improved generalization and data efficiency in identifying diagnostic and prognostic imaging biomarkers.

Causal Inference and Bayesian Networks for Biomarker-Outcome Relationships

This study develops causal graphical models and Bayesian network inference to distinguish biomarker associations from true causal drivers of cancer phenotypes and treatment response. The work generates mechanistic insights into which biomarkers are therapeutic targets versus passive correlates.

Federated Learning for Privacy-Preserving Multi-Institutional Biomarker Discovery

This research implements federated machine learning frameworks that train biomarker models across distributed hospital datasets without centralizing sensitive patient data. The work advances collaborative cancer research by enabling large-scale discovery while maintaining HIPAA compliance and data sovereignty.

Active Learning and Uncertainty Quantification for Optimal Biomarker Sampling

This investigation applies Bayesian uncertainty estimation and active learning algorithms to prioritize which patient samples should be sequenced or analyzed to maximize biomarker discovery efficiency. The work reduces experimental costs and time-to-biomarker by intelligently selecting informative samples.